Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer.
Selective targeting of cancer-associated fibroblasts (CAFs) has been proposed to synergize with immune-checkpoint inhibitors. While the roles of CAFs in cancer development are well described, their immune-regulatory properties remain incompletely understood. This study investigates correlations betw...
Main Authors: | Thomas Karsten Kilvaer, Mehrdad Rakaee, Turid Hellevik, Arne Østman, Carina Strell, Roy M Bremnes, Lill-Tove Busund, Tom Dønnem, Inigo Martinez-Zubiaurre |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5802915?pdf=render |
Similar Items
-
Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC
by: Thomas Karsten Kilvaer, et al.
Published: (2019-07-01) -
Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.
by: Thomas K Kilvaer, et al.
Published: (2015-01-01) -
Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients
by: Smeland Eivind, et al.
Published: (2011-07-01) -
Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced
by: Hellevik Turid, et al.
Published: (2012-04-01) -
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
by: Erna-Elise Paulsen, et al.
Published: (2023-04-01)